MAPT and hippocampal atrophy: Similarly, while CSF p-tau181 is a marker of tau pathology, its relationship with cognitive decline may be more prominent in advanced disease or in association with downstream measures of neurodegeneration, such as hippocampal atrophy or synaptic loss (Apostolova et al., 2010; Jack et al., 2010).